प्रोस्टेट कॅन्सर
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
कुठे जायचं
या trial साठी भारतातील 8 hospitals रुग्ण घेत आहेत.
रजिस्ट्री सारांश (तांत्रिक)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
स्पॉन्सर: Bayer
ClinicalTrials.gov वर NCT05348876
रजिस्ट्रीवर शेवटचे अपडेट 6 Jul 2026 · आम्ही वाचले 20 Oct 2026